4.10
price up icon1.49%   0.06
 
loading
Evotec Se Adr stock is traded at $4.10, with a volume of 11,437. It is up +1.49% in the last 24 hours and up +11.11% over the past month. Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
See More
Previous Close:
$4.04
Open:
$4.06
24h Volume:
11,437
Relative Volume:
0.24
Market Cap:
$1.46B
Revenue:
$842.96M
Net Income/Loss:
$-185.63M
P/E Ratio:
-7.7962
EPS:
-0.5259
Net Cash Flow:
$-228.52M
1W Performance:
+5.67%
1M Performance:
+11.11%
6M Performance:
-2.61%
1Y Performance:
+12.95%
1-Day Range:
Value
$4.06
$4.1108
1-Week Range:
Value
$3.86
$4.1108
52-Week Range:
Value
$2.84
$5.6405

Evotec Se Adr Stock (EVO) Company Profile

Name
Name
Evotec Se Adr
Name
Phone
-
Name
Address
-
Name
Employee
4,766
Name
Twitter
Name
Next Earnings Date
2025-04-17
Name
Latest SEC Filings
Name
EVO's Discussions on Twitter

Compare EVO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
4.11 1.42B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.50 64.74B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.01 44.56B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.285 41.55B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.02 21.78B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
422.91 19.11B 3.08B 1.24B 1.07B 25.61

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-24-25 Upgrade Deutsche Bank Sell → Hold
Oct-07-24 Downgrade Jefferies Buy → Hold
Aug-08-24 Downgrade Deutsche Bank Hold → Sell
Jul-29-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-11-24 Downgrade Deutsche Bank Buy → Hold
Apr-12-24 Upgrade Deutsche Bank Hold → Buy
Jan-18-24 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-23-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-16-23 Downgrade BofA Securities Buy → Neutral
Jun-08-23 Upgrade Citigroup Neutral → Buy
Apr-04-23 Upgrade Morgan Stanley Underweight → Equal-Weight
Dec-09-22 Initiated H.C. Wainwright Buy
Nov-16-22 Downgrade Deutsche Bank Buy → Hold
Aug-10-22 Downgrade Morgan Stanley Overweight → Underweight
Mar-02-22 Resumed Cowen Outperform
Jan-07-22 Resumed Citigroup Neutral
View All

Evotec Se Adr Stock (EVO) Latest News

pulisher
Oct 13, 2025

ETFs Investing in Evotec SE Sponsored ADR Stocks - TradingView

Oct 13, 2025
pulisher
Oct 07, 2025

Evotec (NASDAQ:EVO) versus CASI Pharmaceuticals (NASDAQ:CASI) Critical Survey - Defense World

Oct 07, 2025
pulisher
Oct 02, 2025

Kazia Therapeutics Announces 86% Reduction in Tumor Burden in Expanded-Access Case of Metastatic TNBC Patient Treated with Paxalisib-Immunotherapy Regimen - Benzinga

Oct 02, 2025
pulisher
Sep 07, 2025

Evotec Ag’s Earnings Call: Mixed Sentiments and Strategic Moves - MSN

Sep 07, 2025
pulisher
Aug 28, 2025

Stock Information - Evotec

Aug 28, 2025
pulisher
Aug 28, 2025

Annual General Meeting - Evotec

Aug 28, 2025
pulisher
Aug 14, 2025

Evotec SE ADR earnings missed by $0.07, revenue fell short of estimates - Investing.com South Africa

Aug 14, 2025
pulisher
Aug 14, 2025

Evotec AG Reports Mixed H1 2025 Performance - TipRanks

Aug 14, 2025
pulisher
Aug 11, 2025

Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion11.08.25NewsARIVA.DE - rova

Aug 11, 2025
pulisher
Aug 02, 2025

Evotec shares drop sharply after lowering 2025 revenue forecast - MSN

Aug 02, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site - Investing.com

Jul 30, 2025
pulisher
Jul 26, 2025

Evotec SE (EVO) Stock Forecasts - Yahoo Finance

Jul 26, 2025
pulisher
Jul 25, 2025

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union - Ariva

Jul 25, 2025
pulisher
Jul 22, 2025

SAP Quarterly Statement Q2 202522.07.25News - Ariva

Jul 22, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jun 04, 2025

8 New 4-Star Stocks - Morningstar

Jun 04, 2025
pulisher
May 24, 2025

Evotec SE ADR (EVO) Strikes $4.73: The Risk Seems Worthwhile At This Price - Stocksregister

May 24, 2025
pulisher
May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Evotec Ag Earnings Call: Mixed Sentiment Amid Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

May 07, 2025
pulisher
Apr 24, 2025

Evotec shares surge 51% following InvestingPro’s undervalued signal By Investing.com - Investing.com

Apr 24, 2025
pulisher
Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com India

Apr 18, 2025
pulisher
Apr 17, 2025

Evotec SE Reports Strong Q4 2024 and New Strategy - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec Ag’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec: Management Streamlines Strategy to Refocus on Core Strengths Amid Biologics Momentum - Morningstar

Apr 17, 2025
pulisher
Apr 08, 2025

Bayer, BioNxt Solutions, Evotec – falscher Zoll Alarm bei Pharma und Biotech! Welche Aktien lohnen sich? - kapitalerhoehungen.de

Apr 08, 2025
pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 15, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - Baystreet.ca

Nov 15, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 14, 2024

Earnings call: Evotec SE revises 2024 outlook amid market challenges - Investing.com

Aug 14, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar Canada

Aug 13, 2024

Evotec Se Adr Stock (EVO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$49.89
price up icon 2.93%
$22.20
price up icon 1.95%
$10.38
price up icon 0.78%
drug_manufacturers_specialty_generic RDY
$14.66
price up icon 0.31%
$143.08
price down icon 0.40%
$422.91
price down icon 0.51%
Cap:     |  Volume (24h):